| scholarly article | Q13442814 |
| P2093 | author name string | Kris Thielemans | |
| Joeri L Aerts | |||
| Sandra Van Lint | |||
| Sarah K Maenhout | |||
| Perpetua U Emeagi | |||
| P2860 | cites work | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 |
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Cancer despite immunosurveillance: immunoselection and immunosubversion | Q28263865 | ||
| Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 | ||
| IDO expression by dendritic cells: tolerance and tryptophan catabolism | Q29614752 | ||
| Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine | Q33584867 | ||
| Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling | Q33772651 | ||
| Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells | Q33873201 | ||
| Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells | Q33919954 | ||
| HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment | Q34243443 | ||
| Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells | Q34312635 | ||
| Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells | Q34597798 | ||
| Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 | ||
| Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells | Q35052425 | ||
| Does the immune system see tumors as foreign or self? | Q35077428 | ||
| The balance of immune responses: costimulation verse coinhibition | Q35998858 | ||
| Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy | Q36108095 | ||
| Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression | Q36259867 | ||
| Myeloid derived suppressor cells in human diseases | Q36338349 | ||
| The B7 family and cancer therapy: costimulation and coinhibition | Q36944386 | ||
| Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity | Q36996588 | ||
| The complex role of B7 molecules in tumor immunology | Q37304913 | ||
| Myeloid-derived suppressor cell heterogeneity and subset definition. | Q37695457 | ||
| Subsets, expansion and activation of myeloid-derived suppressor cells | Q37727050 | ||
| Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family | Q37864700 | ||
| Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients | Q37961577 | ||
| T-regulatory cells: key players in tumor immune escape and angiogenesis | Q38006901 | ||
| On the armament and appearances of human myeloid-derived suppressor cells | Q38031742 | ||
| Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. | Q39244686 | ||
| Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas | Q39424337 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells | Q40259796 | ||
| Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis | Q40339595 | ||
| Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. | Q40836916 | ||
| The terminology issue for myeloid-derived suppressor cells | Q42425163 | ||
| In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site | Q42728755 | ||
| Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells | Q43582877 | ||
| Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo | Q45197119 | ||
| CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells | Q47192084 | ||
| Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. | Q55056515 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1077-1090 | |
| P577 | publication date | 2013-09-23 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts | |
| P478 | volume | 134 |
| Q36413721 | A core of kinase-regulated interactomes defines the neoplastic MDSC lineage |
| Q34365909 | A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice |
| Q34334399 | AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells. |
| Q42124738 | Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy |
| Q35798966 | Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model. |
| Q26750382 | Cancer-Associated Myeloid Regulatory Cells |
| Q40903579 | Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients |
| Q37447879 | Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs |
| Q57817490 | Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy |
| Q38993068 | Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. |
| Q38592376 | Drafting the proteome landscape of myeloid-derived suppressor cells. |
| Q37107253 | Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model. |
| Q35828574 | Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer |
| Q58542370 | Gemcitabine nanoparticles promote antitumor immunity against melanoma |
| Q36597506 | Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells |
| Q36638606 | Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours |
| Q34654430 | Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity |
| Q42840029 | Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells |
| Q92794706 | Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q98465646 | Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation |
| Q89613164 | Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q37732211 | Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection |
| Q92853591 | Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells |
| Q28080262 | Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy |
| Q41968526 | TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function |
| Q28388630 | The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q33660069 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. |
| Q38239562 | The roles of myeloid-derived suppressor cells in transplantation |
| Q59799202 | Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression |
| Q58780996 | Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression |
Search more.